Anuh Pharma announced that its manufacturing facilities located at E-17/3, E-17/4 and E-18, MIDC, Tarapur (Boisar), Palghar, Maharashtra have undergone inspection conducted by the United States Food and Drug Administration (USFDA). The inspection was completed with no Form 483 observations issued.Powered by Capital Market - Live News

Net profit of Anuh Pharma rose 30.08% to Rs 13.45 crore in the quarter ended December 2025 as against Rs 10.34 crore during the previous quarter ended December 2024. Sales rose 23.62% to Rs 197.18 crore in the quarter ended December 2025 as against Rs 159.51 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales197.18159.51 24 OPM %8.529.27 - PBDT20.8215.44 35 PBT17.8213.26 34 NP13.4510.34 30 Powered by Capital Market - Live News

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live News

Net profit of Anuh Pharma declined 49.40% to Rs 7.61 crore in the quarter ended September 2025 as against Rs 15.04 crore during the previous quarter ended September 2024. Sales rose 12.01% to Rs 185.88 crore in the quarter ended September 2025 as against Rs 165.95 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales185.88165.95 12 OPM %6.3910.17 - PBDT12.7820.11 -36 PBT9.9218.19 -45 NP7.6115.04 -49 Powered by Capital Market - Live News

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 7 November 2025.Powered by Capital Market - Live News